Artemis Bioservices assists biotech and pharmaceutical companies to accelerate the development of novel antiviral drugs and viral vaccines, especially against emerging, zoonotic, vector-borne and other neglected diseases.
Our mission is to assist biotech and pharmaceutical companies to accelerate the development and licensing of safe and effective intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro and in-vivo immunogenicity and efficacy testing.
By providing extensive preclinical immunogenicity and efficacy data integrated with sophisticated bioinformatics analysis, Artemis Bioservices is a valuable partner to help you reach your goals.
Our vision is to become a strategic partner in the process of antiviral and vaccine development, especially against emerging, zoonotic and arboviral diseases, to facilitate rapid access to safe and effective intervention strategies where and when they are needed the most.
Our scientists, with demonstrated experience in virology, immunology and vaccinology, understand your challenges and can work with you to provide effective solutions tailored to your needs.
We hold ourselves to the highest moral and ethical principles.
We deliver the highest quality in everything we do.
We treat each other like family.
We are committed to helping you achieve your professional dreams.
We do not compromise on health, safety and security.
We act responsibly and always consider our impact on the planet, people and communities with whom we operate.
